In this issue:
- 20-year trends in cardiovascular disease incidence in the UK
- ASCVD burden in patients aged 20–54 years vs over 55 years
- Combined treatment with GLP-1 agonists and SGLT2 inhibitors in type 2 diabetics
- Benefits of statin adherence after STEMI
- Prognostic value of cardiovascular biomarkers
- Aspirin vs clopidogrel for long-term maintenance after coronary stenting
- Factors associated with CIED-related infections
- Benefits and risks of statin therapy for primary prevention in old/very old patients
- Multiple arterial vs single arterial CABG
- Cardiac shockwave therapy in addition to CABG
Please login below to download this issue (PDF)